Patients receiving antitumor treatments may have a higher risk for acquiring SARS-CoV-2 infection than the general population, but overall the incidence appears to be low, say Italian researchers.
Having a high prevalence of chronic conditions associated with severe COVID-19 and an increased risk for influenza hospitalization or death may indicate that cancer survivors are at increased risk poor COVID-19 outcomes, UK study data suggest.